Stealth BioTherapeutics Corp (MITO) Stock Analysis

What Stealth BioTherapeutics Corp does

Stealth BioTherapeutics Corp is a clinical-stage biotechnology firm dedicated to discovering, developing, and bringing to market treatments for illnesses arising from mitochondrial dysfunction. Its primary therapeutic candidate, Elamipretide, is currently progressing through multiple clinical stages: a Phase 3 trial for Barth Syndrome and replisome myopathies; a Phase 2/3 study for Duchenne cardiomyopathy; a Phase 2a investigation for Friedreich's ataxia; and Phase 2 trials for both dry age-related macular degeneration and Leber's hereditary optic neuropathy. The company's developmental pipeline further includes SBT-20, designed to address complications associated with diabetes, various renal and ocular conditions, and several neurodegenerative diseases such as Parkinson's, Alzheimer's, Huntington's, and ALS. Additionally, SBT-550 is being evaluated for rare neurological indications, while SBT-272, a peptidomimetic, is engineered to target and enhance mitochondrial function amidst oxidative stress. Established in 2006, Stealth BioTherapeutics Corp operates from its base in George Town, Cayman Islands.

Key metrics

ETFs linked to MITO

Broad-market and Healthcare sector ETFs an investor holding Stealth BioTherapeutics Corp is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how MITO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Stealth BioTherapeutics Corp?

Stealth BioTherapeutics Corp trades under the ticker MITO on NASDAQ.

Which exchange is MITO listed on?

MITO is listed on NASDAQ.

What sector does Stealth BioTherapeutics Corp operate in?

Stealth BioTherapeutics Corp is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze MITO in a portfolio?

PortView shows MITO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.